NEUTROMAX should not be administered in patients with known hypersensitivity to the active ingredient or its constituents. NEUTROMAX should not be used to increase the dose of cytotoxic chemotherapy beyond established dosage regimens. NEUTROMAX should not be administered to patients with severe congenital neutropenia (Kostmann's syndrome) with abnormal cytogenetics.